Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
General and administrative	$ 13,816	$ 11,039	$ 12,046
Research and development	37,592	41,838	43,717
Total operating expenses	51,408	52,877	55,763
Operating loss	(51,408)	(52,877)	(55,763)
Other income (expense)
Grant income	37	75	25
Research and development incentive income	648	2,291	2,718
Interest income, net	4,678	7,320	6,519
Other financing expense			(964)
Foreign exchange gain (loss)	(332)	189	(40)
Total other income, net	5,031	9,875	8,258
Net loss and comprehensive loss	$ (46,377)	$ (43,002)	$ (47,505)
Net Loss per share
Net Loss per share, Basic	$ (0.54)	$ (0.52)	$ (0.60)
Net Loss per share, Diluted	$ (0.54)	$ (0.52)	$ (0.60)
Weighted average number of shares outstanding
Weighted average number of shares outstanding, Basic	85,289,447	83,468,049	79,787,596
Weighted average number of shares outstanding, Diluted	85,289,447	83,468,049	79,787,596